Certain foods or their components are widely used in the prevention and/or management of cardiovascular disease. Milk proteins have been suggested to have hypotensive properties. A number of clinical trials have been carried out to evaluate the effect of milk proteins from whole foods and supplements on blood pressure (BP). However, the effect of milk proteins on BP is not well understood. Therefore, we conducted a meta-analysis of randomized control trials to provide insight into and robust evidence concerning the overall impact of milk proteins on BP. The PubMed and Cochrane databases were searched for literature concerning the effects of milk proteins on BP up to May 2016. A random effects model was used to calculate the pooled estimates and 95% confidence intervals of effect sizes. The final analysis included seven randomized control trials involving 412 participants. Overall, milk protein interventions significantly lowered systolic BP by −3.33 mm Hg (95% confidence interval −5.62, −1.03) and diastolic BP by −1.08 mm Hg (95% confidence interval −3.38, −0.22). There was no statistical evidence of publication bias across the studies. In conclusion, this meta-analysis provides further evidence that milk proteins slightly but significantly lower both systolic and diastolic BP.
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
World Health Organization 2015. http://www.who.int/cardiovascular_diseases/about_cvd/en/. Accessed May 2016.
World Heart Federation (2012. http://www.world-heart-federation.org/press/fact-sheets/cardiovascular-disease-risk-factors/. Accessed May 2016.
Forman D, Bulwer BE . Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle. Curr Treat Options Cardiovasc Med 2006; 8: 47–57.
Moore LL . Functional foods and cardiovascular disease risk: building the evidence base. Curr Opin Endocrinol Diabetes Obes 2011; 18: 332–335.
Fekete AA, Givens DI, Lovegrove JA . The impact of milk proteins and peptides on blood pressure and vascular function: a review of evidence from human intervention studies. Nutr Res Rev 2013; 26: 177–190.
Daly RM, Nowson CA . Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and serum lipid concentrations in healthy older men. Eur J Clin Nutr 2009; 63: 993–1000.
Pal S, Ellis V . The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity 2010; 18: 1354–1359.
Petrogianni M, Grammatikaki E, Kalogeropoulos N, Peristeraki A, Moschonis G, Pitsavos C, Antonopoulou S, Manios Y . Additional benefit in CVD risk indices derived from the consumption of fortified milk when combined with a lifestyle intervention. Public Health Nutr 2014; 17: 440–449.
Petyaev IM, Dovgalevsky PY, Klochkov VA, Chalyk NE, Kyle N . Whey protein lycosome formulation improves vascular functions and plasma lipids with reduction of markers of inflammation and oxidative stress in prehypertension. ScientificWorldJournal 2012; 2012: 269476.
Vatani DS, Golzar FAK . Changes in antioxidant status and cardiovascular risk factors of overweight young men after six weeks supplementation of whey protein isolate and resistance training. Appetite 2012; 59: 673–678.
Figueroa A, Wong A, Kinsey A, Kalfon R, Eddy W, Ormsbee MJ . Effects of milk proteins and combined exercise training on aortic hemodynamics and arterial stiffness in young obese women with high blood pressure. Am J Hypertens 2014; 27: 338–344.
Lee YJ, Seo JA, Yoon T, Seo I, Lee JH, Im D, Lee JH, Bahn KN, Ham HS, Jeong SA, Kang TS, Ahn JH, Kim DH, Nam GE, Kim NH . Effects of low-fat milk consumption on metabolic and atherogenic biomarkers in Korean adults with the metabolic syndrome: a randomised controlled trial. J Hum Nutr Diet 2016; 29: 477–486.
Pal S, Ellis V . Acute effects of whey protein isolate on blood pressure, vascular function and inflammatory markers in overweight postmenopausal women. Br J Nutr 2011; 105: 1512–1519.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
Dong JY, Szeto IM, Makinen K, Gao Q, Wang J, Qin LQ, Zhao Y . Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 2013; 110: 1188–1194.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ . Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1–12.
Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. http://www.cochrane-handbook.org. Accessed 20 June 2014.
Follmann D, Elliott P, Suh I, Cutler J . Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992; 45: 769–773.
Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.
Duval S . Tweedie RTrim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455–463.
Khalesi S, Sun J, Buys N, Jayasinghe R . Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 2014; 64: 897–903.
Sleight P, Yusuf S, Pogue J, Tsuyuki R, Diaz R, Probstfield J . Heart Outcomes Prevention Evaluation (HOPE) study. Blood-pressure reduction and cardiovascular risk in HOPE study. Lancet 2001; 358: 2130–2131.
Rebholz CM, Friedman EE, Powers LJ, Arroyave WD, He J, Kelly TN . Dietary protein intake and blood pressure: a meta-analysis of randomized controlled trials. Am J Epidemiol 2012; 176: S27–S43.
McCarron DA, Morris CD, Henry HJ, Stanton JL . Blood pressure and nutrient intake in the United States. Science 1984; 224: 1392–1398.
Kris-Etherton PM, Grieger JA, Hilpert KF, West SG . Milk products, dietary patterns and blood pressure management. J Am Coll Nutr 2009; 28: 103S–119S.
Hoffman JR, Falvo MJ . Protein – which is best? J Sports Sci Med 2004; 3: 118–130.
Pal S, Radavelli-Bagatini S . The effects of whey protein on cardiometabolic risk factors. Obes Rev 2013; 14: 324–343.
Nonaka A, Nakamura T, Hirota T, Matsushita A, Asakura M, Ohki K, Kitakaze M . The milk-derived peptides Val-Pro-Pro and Ile-Pro-Pro attenuate arterial dysfunction in L-NAME-treated rats. Hypertens Res 2014; 37: 703–707.
FitzGerald RJ, Murray BA, Walsh DJ . Hypotensive peptides from milk proteins. J Nutr 2004; 134: 980–998.
FitzGerald RJ, Meisel H . Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 2000; 84: 33–37.
Abubakar A, Saito T, Kitazawa H, Kawai Y, Itoh T . Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J Dairy Sci 1998; 81: 3131–3138.
Nurminen ML, Sipola M, Kaarto H, Pihlanto-Leppälä A, Piilola K, Korpela R, Tossavainen O, Korhonen H, Vapaatalo H . Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 2000; 66: 1535–1543.
Buendia JR, Bradlee ML, Singer MR, Moore LL . Diets higher in protein predict lower high blood pressure risk in Framingham Offspring Study adults. Am J Hypertens 2015; 28: 372–379.
Altorf-van der Kuil W, Engberink MF, Brink EJ, van Baak MA, Bakker SJ, Navis G, van 't Veer P, Geleijnse JM . Dietary protein and blood pressure: a systematic review. PLoS ONE 2010; 5: e12102.
He J, Whelton PK . Effect of dietary fiber and protein intake on blood pressure: a review of epidemiologic evidence. Clin Exp Hypertens 1999; 21: 785–796.
Liu L, Ikeda K, Sullivan DH, Ling W, Yamori Y . Epidemiological evidence of the association between dietary protein intake and blood pressure: a meta-analysis of published data. Hypertens Res 2002; 25: 689–695.
Obarzanek E, Velletri PA, Cutler JA . Dietary protein and blood pressure. JAMA 1996; 275: 1598–1603.
Sved AF, Van Itallie CM, Fernstrom JD . Studies on the antihypertensive action of L-tryptophan. J Pharmacol Exp Ther 1982; 221: 329–333.
Ardiansyah, Shirakawa H, Inagawa Y, Koseki T, Komai M . Regulation of blood pressure and glucose metabolism induced by L-tryptophan in stroke-prone spontaneously hypertensive rats. Nutr Metab (Lond) 2011; 8: 45.
Pietinen P, Aro A . The role of nutrition in the prevention and treatment of hypertension. Adv Nutr Res 1990; 8: 35–78.
Pinto E . Blood pressure and ageing. Postgrad Med J 2007; 83: 109–114.
Atkinson AB, Robertson JIS . Captopril in the treatment of clinical hypertension and cardiac-failure. Lancet 1979; 2: 836–839.
Gavras H, Gavras I . Angiotensin converting enzyme inhibitors properties and side effects. Hypertension 1988; 11: 37.
The study was supported by grants from the National Natural Science Foundation of China (no. 81472974 and no. 81273067) and from the Food and Drug Administration of Hebei province 2015 annual food and drug safety science and technology project plan (ZD2015019).
The authors declare no conflict of interest.
Supplementary Information accompanies the paper on Hypertension Research website
About this article
Cite this article
Hidayat, K., Du, HZ., Yang, J. et al. Effects of milk proteins on blood pressure: a meta-analysis of randomized control trials. Hypertens Res 40, 264–270 (2017). https://doi.org/10.1038/hr.2016.135
- blood pressure
- milk protein
- randomized control trial